NCT02862847

Brief Summary

Cosavirus and Salivirus are two new genera of Picornaviridae and are responsible for acute diarrhoea. They have been identified in the pathological stools of infants and immuno-compromised subjects on every continent with prevalences ranging from 2.8% to 8.8% depending on the virus, the cohort and the country studied. To date, no study on these two viruses has been conducted in France to evaluate the circulation and the pathogenicity of these viruses in subjects with diarrhoea. The aim of this study is thus to:

  • show that these viruses are in circulation in France in infants younger than 5 years old and that the proportions are similar to those reported in the literature.
  • confirm the relationship between the diarrhoea and the infection with these viruses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
615

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 4, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 11, 2016

Completed
Last Updated

August 11, 2016

Status Verified

July 1, 2016

Enrollment Period

1 year

First QC Date

August 4, 2016

Last Update Submit

August 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of viruses detected

    Baseline

Study Arms (2)

gastroenteritis

Other: stool samples

control

Other: stool samples

Interventions

controlgastroenteritis

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

children de moins de 5ans présentant ou non un épisode de gasto entérite

You may qualify if:

  • Children younger than 5 years
  • Children hospitalized or consulting at Dijon CHU during the 12 months of the study for acute gastroenteritis. Acute gastroenteritis is defined by at least 3 soft or liquid stools or at least 3 bouts of vomiting within 24 hours or signs (diarrhoea or vomiting) accompanied by at least 2 additional symptoms among diarrhoea or vomiting, abdominal pain, fever
  • for controls
  • Children younger than 5 years old

You may not qualify if:

  • Persons without national health insurance cover
  • Children older than 5 years.
  • Children presenting chronic diarrhoea (\> 2 weeks) (e.g. Crohn and UC)
  • Children with immune deficiency.
  • Children with nosocomial gastroenteritis; the nosocomial aspect will be defined as the onset of acute diarrhoea occurring after the 48th hour after admission
  • for controls
  • Persons without national health insurance cover
  • Children older than 5 years.
  • Children with chronic diarrhoea (\> 2 weeks) (e.g. Crohn and UC)
  • Children with immune deficiency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Dijon Bourgogne

Dijon, 21079, France

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2016

First Posted

August 11, 2016

Study Start

July 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

August 11, 2016

Record last verified: 2016-07

Locations